PedOncDoc -
Quote:
|
In my field of expertise we treat profoundly immunocompromised patients who have no immunologic reserve and can go from well-appearing to dead in a matter of hours, so our treatment algorithms typically start broad and go to narrow - the opposite of what should be done for otherwise immunocompetent patients.
|
I haven't forgotten our earlier discussions. Capital raise has take all of my time
but we are almost done.
In addition to the oncology application, I think our indirect (UW) approach to infection prevention will be useful in the immunocompromised kids. Mechanism of action data suggests that is the case. We plan to test this in mildly immunosuppressed mice (morphine) to mimic combat casualty cases.
More later and via email.
Hope you are enjoying your new digs.